Oteseconazole is an antifungal prescription medicine approved by the Food and Drug Administration (FDA) to reduce the risk of recurrent vulvovaginal candidiasis in females who are not pregnant and who are not able to become pregnant. Vulvovaginal candidiasis can be an opportunistic infection (OI) of HIV. Its therapeutic use is listed as anti-infectives, antifungals and dermatologicals. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Vivijoa (TN), oteseconazolum and VT-1161. Its PubChem CID is 77050711.
Oteseconazole
| CAS No | 1340593-59-0 |
|---|---|
| Molecular Formula | C23H16F7N5O2 |
| Molecular Weight | 527.4 g/mol |
| Synonyms | (2R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl]propan-2-ol |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Oteseconazole is an antifungal prescription medicine approved by the Food and Drug Administration (FDA) to reduce the risk of recurrent vulvovaginal candidiasis in females who are not pregnant and who are not able to become pregnant.
The listed CAS number is 1340593-59-0.
The listed molecular formula is C23H16F7N5O2.
The listed molecular weight is 527.4 g/mol.
(2R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl]propan-2-ol.
The source lists Vivijoa (TN), oteseconazolum and VT-1161.